We explore how GLP-1 works and how it can transform your overall well-being, including your intimate life
Your physician adjusts your dosage based on bloodwork results and how your body responds-usually checked at 4 weeks, 8 weeks, and then every 12 weeks
Semaglutide improves insulin sensitivity primarily through GLP-1 receptor-mediated reductions in glucagon secretion, improved beta-cell function, and indirect effects from weight loss
Approval for Diabetes and Weight Management Over the past decade, three GLP-1/GIP receptor agonists liraglutide, semaglutide, and tirzepatide initially approved by the FDA for adults with type 2 diabetes, have also gained FDA approval for chronic weight management in people without diabetes, provided they meet specific criteria: a BMI of 30, or 27 with at least one weight-related condition such as hypertension, dyslipidemia, or type 2 diabetes
The regulatory status of these compounds may evolve, requiring ongoing attention to legal requirements
There is no penalty for moving slowly